{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T07:44:48Z","timestamp":1768895088113,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T00:00:00Z","timestamp":1435622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s10238-015-0369-y","type":"journal-article","created":{"date-parts":[[2015,6,29]],"date-time":"2015-06-29T03:54:33Z","timestamp":1435550073000},"page":"375-382","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pathological and prognostic significance of matrix metalloproteinase-2 expression in ovarian cancer: a meta-analysis"],"prefix":"10.1007","volume":"16","author":[{"given":"Chao","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,30]]},"reference":[{"key":"369_CR1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics 2012. CA Cancer J Clin. 2012;62:10\u201329.","journal-title":"CA Cancer J Clin"},{"key":"369_CR2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3802\/jgo.2013.24.4.342","volume":"24","author":"YC Chiang","year":"2013","unstructured":"Chiang YC, Chen CA, Chiang CJ, et al. Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan. J Gynecol Oncol. 2013;24:342\u201351.","journal-title":"J Gynecol Oncol"},{"key":"369_CR3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1615\/CritRevEukarGeneExpr.v6.i4.40","volume":"6","author":"MP Vincenti","year":"1996","unstructured":"Vincenti MP, White LA, Schroen DJ, Benbow U, Brinckerhoff CE. Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability. Crit Rev Eukaryo Gene Expr. 1996;6:391\u2013411.","journal-title":"Crit Rev Eukaryo Gene Expr"},{"key":"369_CR4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0046-8177(00)80242-7","volume":"31","author":"FB Galateau-Salle","year":"2000","unstructured":"Galateau-Salle FB, Luna RE, Horiba K, et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in bronchial squamous preinvasive lesions. Hum Pathol. 2000;31:296\u2013305.","journal-title":"Hum Pathol"},{"key":"369_CR5","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.1016\/S0021-9258(18)68680-6","volume":"263","author":"IE Collier","year":"1988","unstructured":"Collier IE, Wilhelm SM, Eisen AZ, et al. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem. 1988;263:6579\u201387.","journal-title":"J Biol Chem"},{"key":"369_CR6","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","volume":"274","author":"H Nagase","year":"1999","unstructured":"Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem. 1999;274:21491\u20134.","journal-title":"J Biol Chem"},{"key":"369_CR7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1515\/bchm.1997.378.2.71","volume":"378","author":"H Kolkenbrock","year":"1997","unstructured":"Kolkenbrock H, Hecker-Kia A, Orgel D, Ulbrich N, Will H. Activation of progelatinase A and progelatinase A\/TIMP-2 complex by membrane type 2-matrix metalloproteinase. Biol Chem. 1997;378:71\u20136.","journal-title":"Biol Chem"},{"key":"369_CR8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.oraloncology.2005.07.008","volume":"42","author":"P O-Charoenrat","year":"2006","unstructured":"O-Charoenrat P, Khantapura P. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer. Oral Oncol. 2006;42:257\u201367.","journal-title":"Oral Oncol"},{"key":"369_CR9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1006\/gyno.2001.6477","volume":"84","author":"X Wu","year":"2002","unstructured":"Wu X, Li H, Kang L, Li L, Wang W, Shan B. Activated matrix metalloproteinase-2-a potential marker of prognosis for epithelial ovarian cancer. Gynecol Oncol. 2002;84:126\u201334.","journal-title":"Gynecol Oncol"},{"key":"369_CR10","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S1701-2163(16)34527-3","volume":"32","author":"H Kamel","year":"2010","unstructured":"Kamel H, Abdelazim I, Habib SM, El Shourbagy MA, Ahmed NS. Immunoexpression of matrix metalloproteinase-2 (MMP-2) in malignant ovarian epithelial tumours. J Obstet Gynaecol Can. 2010;32:580\u20136.","journal-title":"J Obstet Gynaecol Can"},{"key":"369_CR11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S2305-0500(13)60134-7","volume":"2","author":"IA Abdelazim","year":"2013","unstructured":"Abdelazim IA, Al-Kadi M. Immunoexpression of matrix metalloproteinase-2 (MMP-2) in epithelial ovarian cancers (EOCs). Asian Pac J Reprod. 2013;2:136\u201341.","journal-title":"Asian Pac J Reprod"},{"key":"369_CR12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1600-0463.2008.00003.x","volume":"117","author":"CK Lin","year":"2009","unstructured":"Lin CK, Chao TK, Yu CP, Yu MH, Jin JS. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters. APMIS. 2009;117:162\u201375.","journal-title":"APMIS"},{"key":"369_CR13","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0959-8049(03)00427-1","volume":"39","author":"L Manenti","year":"2003","unstructured":"Manenti L, Paganoni P, Floriani I, et al. Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma. Eur J Cancer. 2003;39:1948\u201356.","journal-title":"Eur J Cancer"},{"key":"369_CR14","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/mc.20273","volume":"46","author":"KQ Cai","year":"2007","unstructured":"Cai KQ, Yang WL, Capo-Chichi CD, et al. Prominent expression of metalloproteinases in early stages of ovarian tumorigenesis. Mol Carcinog. 2007;46:130\u201343.","journal-title":"Mol Carcinog"},{"key":"369_CR15","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ygyno.2003.11.011","volume":"92","author":"PL Torng","year":"2004","unstructured":"Torng PL, Mao TL, Chan WY, Huang SC, Lin CT. Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression. Gynecol Oncol. 2004;92:559\u201367.","journal-title":"Gynecol Oncol"},{"key":"369_CR16","unstructured":"Zhang H. Expression and clinical significance of GLUT-1 and MMP-2 in the tissue of human malignant ovarian tumor. Wanfang Master Thesis Database. 2005."},{"key":"369_CR17","first-page":"1165","volume":"32","author":"JX Wu","year":"2007","unstructured":"Wu JX, Zhao Y, Jia SJ, Li YY. Expressions of MMP-2, MMP-3, MMP-9 and CD147 in human ovarian cancer and their clinicopathological significance. J Chongqing Med Univ. 2007;32:1165\u20138.","journal-title":"J Chongqing Med Univ"},{"key":"369_CR18","unstructured":"Wang J. Expression and significance of osteopontin, MMp-2 in epithelial ovarian tumor. Wanfang Master Thesis Database. 2007."},{"key":"369_CR19","first-page":"88","volume":"28","author":"YH Luo","year":"2007","unstructured":"Luo YH, He AB, Zhang YQ. The unbalanced expression of MMP-2 and TIMP-2 and its correlations with angiogenesis in epithelial ovarian neoplasm. An Hui Yi Xue. 2007;28:88\u201390.","journal-title":"An Hui Yi Xue"},{"key":"369_CR20","first-page":"1968","volume":"25","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Chen Y, Wei L. Expressions of VEGF165 and MMP2 in epithelial ovarian cancer. J Clin Res. 2008;25:1968\u201370.","journal-title":"J Clin Res"},{"key":"369_CR21","first-page":"1042","volume":"34","author":"Y Pan","year":"2008","unstructured":"Pan Y, Zhu D, Si N, Zhang W. Expressions of RhoC and MMP-2 proteins in epithelial ovarian cancer tissues and their clinical significances. J Jilin Univ. 2008;34:1042\u20135.","journal-title":"J Jilin Univ"},{"key":"369_CR22","first-page":"1694","volume":"8","author":"Y Liu","year":"2008","unstructured":"Liu Y, Zhang Y, Kuang H, Kong C. Expression of MMP2 protein in epithelial ovarian cancer tissue. China Trop Med. 2008;8:1694\u20135.","journal-title":"China Trop Med"},{"key":"369_CR23","unstructured":"Zhu G. Expression and significance of OPN, CD44v6, MMp-2 in epithelial ovarian tumor. Wanfang Master Thesis Database. 2008."},{"key":"369_CR24","first-page":"726","volume":"13","author":"H Li","year":"2009","unstructured":"Li H, Su Y, Wu J, Zhang J, Dou Z, Li Y. Expression and clinical significance of MMP-2 and VEGF in ovarian carcinoma. Chin J Lab Diagn. 2009;13:726\u20139.","journal-title":"Chin J Lab Diagn"},{"key":"369_CR25","first-page":"747","volume":"36","author":"H Sun","year":"2009","unstructured":"Sun H, Yan X, Li R, Wang X, Zhang Y. Expression and significance of CXCR4 and MMP-2 in human ovarian epithelial tumors. Zhong Liu Fang Zhi Yan Jiu. 2009;36:747\u20139.","journal-title":"Zhong Liu Fang Zhi Yan Jiu"},{"key":"369_CR26","first-page":"1531","volume":"16","author":"T Wang","year":"2009","unstructured":"Wang T. Explore the relationship between VEGF and MMP-2 and ovarian cancer ascites and abdominal metastases. Pract Prev Med. 2009;16:1531\u20132.","journal-title":"Pract Prev Med"},{"key":"369_CR27","first-page":"563","volume":"7","author":"Y Liu","year":"2009","unstructured":"Liu Y, Lv J, Chen Y, Lin M. Expressions of claudin-4 and MMP-2 in epithelial ovarian tumor. Oncol Progr. 2009;7:563\u20139.","journal-title":"Oncol Progr"},{"key":"369_CR28","first-page":"2322","volume":"10","author":"X Zeng","year":"2010","unstructured":"Zeng X, Peng Y. Expression and clinical significance of VEGF, MMP-2 and MMP-9 in ovarian carcinoma. Prog Mod Biomed. 2010;10:2322\u20134.","journal-title":"Prog Mod Biomed"},{"key":"369_CR29","unstructured":"Guo J. The expression of HGF, IGF-I and MMP-2 in epithelial ovarian cancer. Wanfang Master Thesis Database. 2010."},{"key":"369_CR30","first-page":"325","volume":"20","author":"L Yu","year":"2011","unstructured":"Yu L, Wang W, Gan H, Wu S, Song W, Guo B. Expression and clinical significance of MMP-2 and MMP-7 in ovarian carcinoma. Chin J Histochem Cytochem. 2011;20:325\u201330.","journal-title":"Chin J Histochem Cytochem"},{"key":"369_CR31","first-page":"208","volume":"9","author":"J Hu","year":"2011","unstructured":"Hu J. Expression of MMP2 and MMP9 in tissue of epithelial tumor of ovary and its clinical significance. Chin Med Mod Distance Educ China. 2011;9:208\u201310.","journal-title":"Chin Med Mod Distance Educ China"},{"key":"369_CR32","first-page":"83","volume":"2","author":"M Su","year":"2011","unstructured":"Su M, Zhang Y, Huang H, Shi G, Sun F, Qiu Y. Expression of HIF-1A and MMP-2 in vasculogenic mimicry of ovarian cancer. Prog Obstet Gynecol. 2011;2:83\u20137.","journal-title":"Prog Obstet Gynecol"},{"key":"369_CR33","first-page":"1406","volume":"35","author":"L Shen","year":"2013","unstructured":"Shen L, Tang L, Zhang J, Zhou S. Expression and significance of WAVE1, MMP-2 and MMP-9 in ovarian cancer. J Third Mil Med Univ. 2013;35:1406\u20139.","journal-title":"J Third Mil Med Univ"},{"key":"369_CR34","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/1746-1596-8-190","volume":"8","author":"L Wang","year":"2013","unstructured":"Wang L, Jin X, Lin D, et al. Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases -2 expression in ovarian carcinoma. Diagn Pathol. 2013;8:190.","journal-title":"Diagn Pathol"},{"key":"369_CR35","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3109\/07357907.2013.820320","volume":"31","author":"PG Grelewski","year":"2013","unstructured":"Grelewski PG, Bar JK. The role of p53 protein and MMP-2 tumor\/stromal cells expression on progressive growth of ovarian neoplasms. Cancer Invest. 2013;31:472\u20139.","journal-title":"Cancer Invest"},{"key":"369_CR36","first-page":"283","volume":"32","author":"S Li","year":"2013","unstructured":"Li S, Mei J. Clinical significance of MMP-2 and COX-2 expression in epithelial ovarian cancers. J Wannan Med Coll. 2013;32:283\u20136.","journal-title":"J Wannan Med Coll"},{"key":"369_CR37","first-page":"650","volume":"22","author":"D Wu","year":"2013","unstructured":"Wu D, Yang J, Yao Y, Zhou Q. Expression and significance of MMP- 2 and its inhibitors in epithelial ovarian carcinoma. Proc Clin Med. 2013;22:650\u20132.","journal-title":"Proc Clin Med"},{"key":"369_CR38","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1053\/beog.2000.0134","volume":"14","author":"MR Brown","year":"2000","unstructured":"Brown MR, Blanchette JO, Kohn EC. Angiogenesis in ovarian cancer. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000;14:901\u201318.","journal-title":"Baillieres Best Pract Res Clin Obstet Gynaecol"},{"key":"369_CR39","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1054\/bjoc.2001.2075","volume":"85","author":"JM Arnold","year":"2001","unstructured":"Arnold JM, Cummings M, Purdie D, Chenevix-Trench G. Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas. Br J Cancer. 2001;85:1351\u20138.","journal-title":"Br J Cancer"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-015-0369-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-015-0369-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-015-0369-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T20:19:03Z","timestamp":1652645943000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-015-0369-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,30]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["369"],"URL":"https:\/\/doi.org\/10.1007\/s10238-015-0369-y","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,30]]}}}